Maze Therapeutics, Inc. MAZE
NASDAQ · United States · Health Technology
$26.65-0.53 (-1.95%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.76 | -0.72 | -6.0% | $0 | -100.0% | +0.9%$27.28→$27.53 |
| Q1 2026 | 2026-05-12 | -0.45 | -0.43 | -4.7% | — | — | +5.6%$25.52→$26.96 |
| Q4 2025 | 2026-03-25 | -0.65 | -0.69 | +5.8% | — | — | -35.3%$49.00→$31.71 |
| Q3 2025 | 2025-11-06 | -0.66 | -0.74 | +10.8% | — | — | -5.5%$30.27→$28.60 |
| Q2 2025 | 2025-08-12 | -0.77 | -1.15 | +33.0% | — | — | — |
| Q1 2025 | 2025-05-14 | -1.15 | -0.63 | -82.5% | — | — | — |
| Q4 2024 | 2025-03-31 | -18.32 | 0.45 | -4,171.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.